# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HOOKIPA Pharma shares are trading lower by 10.9% during Monday's session. The company announced a 1-for-10 reverse stock sp...
HOOKIPA Pharma Inc. (NASDAQ:HOOK, ", HOOKIPA", )))), a company developing a new class of immunotherapeutics based on it...
HC Wainwright & Co. analyst Arthur He maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and raises the price target from...
Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head and neck patients treated wi...